KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Repligen (RGEN) Equity Average (2016 - 2025)

Historic Equity Average for Repligen (RGEN) over the last 15 years, with Q3 2025 value amounting to $2.1 billion.

  • Repligen's Equity Average rose 359.16% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 359.16%. This contributed to the annual value of $2.0 billion for FY2024, which is 160.02% up from last year.
  • According to the latest figures from Q3 2025, Repligen's Equity Average is $2.1 billion, which was up 359.16% from $2.0 billion recorded in Q2 2025.
  • Repligen's Equity Average's 5-year high stood at $2.1 billion during Q3 2025, with a 5-year trough of $1.5 billion in Q1 2021.
  • In the last 5 years, Repligen's Equity Average had a median value of $1.9 billion in 2023 and averaged $1.9 billion.
  • As far as peak fluctuations go, Repligen's Equity Average skyrocketed by 4914.55% in 2021, and later soared by 70.64% in 2025.
  • Repligen's Equity Average (Quarter) stood at $1.7 billion in 2021, then grew by 8.09% to $1.9 billion in 2022, then grew by 5.15% to $2.0 billion in 2023, then increased by 1.29% to $2.0 billion in 2024, then increased by 3.9% to $2.1 billion in 2025.
  • Its last three reported values are $2.1 billion in Q3 2025, $2.0 billion for Q2 2025, and $2.0 billion during Q1 2025.